Cell specific peripheral immune responses indicate that HLA‐DQA1, HLA‐DRB5, and HLA‐DPB1 are the most predictive of survival in CD16 monocytes from critical COVID‐19 patients.37 This evidence concerns the gene HLA-DRB5 and COVID-19.